Sentence examples for major formulations from inspiring English sources

One of the major formulations of this critique came from the utopian and quasi-utilitarian thinker Mozi (470?–391? bce), who rejected what he saw as the implicit hierarchy in ren and opted instead for "universal love" (jianai).

In fact, there are two major formulations of the state space of the Markov chain in the literature.

There are two major formulations of oral morphine: immediate release, which has extensive inter-individual variation for bioavailability and controlled release morphine, which is less variable.

In the past decade, two major formulations of subunit vaccines consisting of F1 and LcrV antigens were developed by such methods as mixing both purified antigens (F1+V) or fusing them together (F1−V).

This translates to an estimated release of 83 ± 81 kg/year of PBDD/Fs to U.S. land as a result of the land application of biosolids; however, the voluntary phase-out of major formulations of PBDEs suggests a likely drop of PBDD/Fs releases in the United States over the course of the past decade.

It would be beyond the scope of this article to evaluate safety in all published articles on botulinum toxins, and therefore only the results of registration trials and selected long-term studies for the 2 major formulations of botulinum toxin type A are presented.

Nevertheless, the major formulation of his religious thought followed customary models, dictated by his formidable role in Buddhist history.

Hemoglobin A1c level and fasting glucose, insulin, and C-peptide levels were not related to duration of current use, age at which use began, or major formulation type.

A population-based case control study involving 1204 non-Asian RCC patients aged 25 74 and an equal number of sex-, age- and race-matched neighbourhood controls was conducted in Los Angeles, California, to investigate the relationship between sustained use of analgesics and risk of RCC according to major formulation categories.

This review will provide a brief discussion of the major nanopharmaceutical formulations as well as the impact of nanotechnology into the future.

This article provides up-to-date information on fundamental properties and mechanisms of action of the major approved formulations of botulinum toxin type A, summarizes recent changes in naming conventions (nonproprietary names) mandated by the United States Food and Drug Administration, and describes the reasons for these changes.